These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22763930)

  • 21. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
    Lang PO; Aspinall R
    Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse effects of the herd immunity or when childhood vaccination becomes deleterious for the epidemiology of infectious diseases in adults].
    Lang PO
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):11-9. PubMed ID: 21586372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prospects for an improvement in the immunoprophylaxis of infectious diseases among the troops].
    Mel'nichenko PI; Ogarkov PI; Ishkil'din MI
    Voen Med Zh; 1999 Jun; 320(6):43-8. PubMed ID: 10439715
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
    Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosoma japonicum: protective immunity induced by schistosomulum-derived cells in a mouse model.
    Cai L; Zeng T; Zeng Q; Li B; Lin X; Gong Y; Liu W; Zhang Z; Zhang S
    J Parasitol; 2008 Apr; 94(2):395-403. PubMed ID: 18564740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herd Immunity: A Brief Review.
    Alam MJ; Rahman MF
    Mymensingh Med J; 2016 Apr; 25(2):392-5. PubMed ID: 27277380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Features of formation of postvaccinal immunity in the population of one-company towns and rural settlements 1].
    Boev MV; Moev VM; Borisov SD
    Gig Sanit; 2012; (3):19-21. PubMed ID: 23088113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinating adults for vaccine-preventable diseases.
    Peterson DC; Bahta L; Ehresmann K
    Minn Med; 2002 Feb; 85(2):37-9. PubMed ID: 11876099
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
    Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
    Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America.
    Immunization Work Group of the National and Global Public Health Committee of the Infectious Diseases Society of America
    Clin Infect Dis; 2007 Jun; 44(12):e104-8. PubMed ID: 17516388
    [No Abstract]   [Full Text] [Related]  

  • 32. Executive summary--Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America.
    Immunization Work Group of the National and Global Public Health Committee of the Infectious Diseases Society of America
    Clin Infect Dis; 2007 Jun; 44(12):1529-31. PubMed ID: 17516393
    [No Abstract]   [Full Text] [Related]  

  • 33. Keeping our adult patients healthy and active: the role of vaccines across the lifespan.
    Schaffner W; Rehm SJ; File TM
    Phys Sportsmed; 2010 Dec; 38(4):35-47. PubMed ID: 21150140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sri Lanka: an innovative approach to the implementation of integrated parasite control, nutrition and family planning projects.
    Devendra T
    Asian Pac Popul Programme News; 1984; 13(1):28-31. PubMed ID: 12313055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of post-vaccination immunity against yellow fever in adults.
    Collaborative group for studies on yellow fever vaccines
    Vaccine; 2014 Sep; 32(39):4977-84. PubMed ID: 25090646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The 2014 Swiss adults immunization schedule: guidelines for medical practitionners].
    Majchrzak DK; Barroussel R; Jackson Y
    Rev Med Suisse; 2014 Sep; 10(443):1779-82, 1784-5. PubMed ID: 25369698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka.
    Wijesinghe PR; Abeysinghe MR; Yoksan S; Yao Y; Zhou B; Zhang L; Yaich M; Neuzil KM; Victor JC
    Vaccine; 2014 Aug; 32(37):4751-7. PubMed ID: 24951871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage.
    Plans-Rubió P
    Hum Vaccin Immunother; 2012 Feb; 8(2):184-8. PubMed ID: 22426372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participatory decision-making through the Advisory Committee on Communicable Diseases: the Sri Lankan experience.
    Wijesinghe PR; Palihawadana P; Peiris TS
    Vaccine; 2010 Apr; 28 Suppl 1():A96-103. PubMed ID: 20413007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccinations: the necessary and the desirable].
    Matter L
    Schweiz Med Wochenschr; 1997 Mar; 127(10):377-81. PubMed ID: 9132924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.